| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |